HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 49 filers reported holding HARPOON THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $40,149 | +175.0% | 53,949 | +168.1% | 0.00% | – |
Q4 2022 | $14,600 | -81.0% | 20,119 | -50.0% | 0.00% | – |
Q2 2022 | $77,000 | -72.3% | 40,223 | -28.1% | 0.00% | – |
Q1 2022 | $278,000 | -77.4% | 55,942 | -65.6% | 0.00% | – |
Q4 2021 | $1,230,000 | +22.6% | 162,574 | +28.0% | 0.00% | – |
Q3 2021 | $1,003,000 | -45.2% | 127,030 | -3.7% | 0.00% | – |
Q2 2021 | $1,831,000 | -45.6% | 131,948 | -18.0% | 0.00% | – |
Q1 2021 | $3,368,000 | -30.3% | 160,964 | -44.6% | 0.00% | – |
Q4 2020 | $4,830,000 | +195.2% | 290,810 | +201.8% | 0.00% | – |
Q3 2020 | $1,636,000 | – | 96,360 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 3,156,699 | $2,335,957 | 1.93% |
MPM ASSET MANAGEMENT LLC | 3,131,388 | $2,329,753 | 0.97% |
MPM BioImpact LLC | 3,196,707 | $2,378,350 | 0.62% |
Lion Point Capital, LP | 169,283 | $125,980 | 0.05% |
Artal Group S.A. | 1,000,000 | $744 | 0.04% |
Cormorant Asset Management, LP | 540,600 | $402 | 0.03% |
KENNEDY CAPITAL MANAGEMENT LLC | 529,934 | $394,377 | 0.01% |
Orbimed Advisors | 621,218 | $462,310 | 0.01% |
Tekla Capital Management LLC | 259,910 | $193,425 | 0.01% |
CM WEALTH ADVISORS LLC | 50,354 | $29 | 0.01% |